Sequence Similarity Clusters for the Entities in PDB 1RZ7

Entity #1 | Chains: L
Fab 48d light chain protein, length: 212 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 1 4 17059
95 % 1 5 10293 Flexibility: Low
Max RMSD: 7.7, Avg RMSD: 2.3
PDBFlex
90 % 198 793 2
70 % 609 2593 1
50 % 1262 5263 1
40 % 1488 5933 1
30 % 1814 7388 1
Entity #2 | Chains: H
Fab 48d heavy chain protein, length: 219 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 1 4 16856
95 % 1 5 10267 Flexibility: Low
Max RMSD: 1.6, Avg RMSD: 1.1
PDBFlex
90 % 1 5 10133
70 % 610 2550 2
50 % 1263 5263 1
40 % 1489 5933 1
30 % 1815 7388 1

Instructions

In the table for each entity, view a list of similar sequences by selecting the link associated with the percentage cutoff.



View more detailed documentation on the redundancy reduction and sequence clustering procedure used by RCSB PDB.

You can also use the structure comparison tool to compare any 2 given structures


ACTION - (A) Select for download / view details OR (B) Select two chains for comparison
Rank PDB ID Entity ID Chains Description Details Taxonomy EC Number
1 5IVN 1 A BC2-nanobody 30538
2 5E7B 1 A nanobody nano-L06 9838
3 2P45 2 B ANTIBODY CAB-RN05 9838
4 2X1Q 1 A, B GELSOLIN NANOBODY 9844
5 5U64 1 B VHH-28 9838
6 6APO 1 A Anti-Marburgvirus Nucleoprotein Single Domain Antibody A 9844
7 2X1P 1 A, B, C, D GELSOLIN NANOBODY 9844
8 4B41 1 A, B ANTIBODY G7 9844
9 4NZU 1 L 13PL heavy chain Fab 9606
10 4NZU 2 H 13PL light chain Fab 9606
11 1MJU 1 L IMMUNOGLOBULIN MS6-12 Fab fragment, LIGHT CHAIN 10090
12 1MJU 2 H IMMUNOGLOBULIN MS6-12 Fab fragment, HEAVY CHAIN 10090
13 5IMM 1 B Nanobody 9835
14 4QYO 1 A Fv fragment(mAb6D8) heavy chain 10090
15 5NLU 1 A single domain llama antibody Nb36 9844
16 4TRP 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
17 4TRP 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
18 1MEX 1 L Fab 29G12 light chain 10090
19 1MEX 2 H Fab 29G12 heavy chain 10090
20 1MQK 2 H antibody 7E2 FV fragment, heavy chain 10090
21 5IMK 1 B Nanobody 9835
22 3D9A 2 L Light Chain of HyHel10 Antibody Fragment (Fab) 10090
23 3D9A 3 H Heavy Chain of HyHel10 Antibody Fragment (Fab) 10090
24 3TPK 1 A Immunoglobulin heavy chain antibody variable domain KW1 9835
25 4BUH 1 A, B CLONE M0418 SCFV 9606
26 4B50 1 A 2H10 LLAMA VHH 9844
27 3TV3 1 L PGT128 light chain, Ig lambda-2 chain C regions PGT128 light chain 9606
28 3TV3 2 H PGT128 heavy chain, Ig gamma-1 chain C region PGT128 heavy chain 9606
29 1NCW 1 L IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, light chain 10090
30 1NCW 2 H IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, heavy chain 10090
31 6DBA 1 A, B nanobody VHH R303 9838
32 5YD4 1 A, C, E, G scFv 4B08 10090
33 5YD3 1 A, C, E, G scFv 4B08 10090
34 2XT1 2 B CAMELID VHH 9 30538
35 5UD9 1 H Fab heavy chain 9606
36 5UD9 2 L Light chain 9606
37 4QY8 1 A Fv fragment(mAb6D8) heavy chain 10090
38 4P48 1 A Antibody scFv 180 9031
39 5VLV 1 A Single Domain Camelid Nanobody VHH T9 9844
40 5TY6 1 H VRC 315 13-1b02 Fab Heavy chain 9606
41 5TY6 2 L VRC 315 13-1b02 Fab Light chain 9606
42 2XZC 1 H FAB A.17 HEAVY CHAIN 9606
43 2XZC 2 L FAB A.17 LIGHT CHAIN 9606
44 5J1S 3 C VHH domain BS-2 30538
45 2XKN 1 A, C ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT LIGHT CHAIN (IGG1), RESIDUES 1-223 10090
46 2XKN 2 B, D ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT HEAVY CHAIN (IGG1), RESIDUES 1-216 10090
47 2P49 2 B ANTIBODY CAB-RN05 TRUNCATED AT RESIDUE 121 9838
48 5J1T 3 C VHH domain BS-2 30538
49 5KVG 2 L ZV-67 Antibody Fab Light Chain 10090
50 5KVG 3 H ZV-67 Antibody Fab Heavy Chain 10090
51 5WCA 1 H VRC315 27-1C08 Fab Heavy chain 9606
52 5WCA 2 L VRC315 27-1C08 Fab Light chain 9606
53 4XCF 1 L 4E10 Fab light chain 9606
54 4XCF 2 H 4E10 Fab heavy chain 9606
55 5M13 2 B synthetic Nanobody L2_C06 (a-MBP#2) 32630
56 5KVF 2 L ZV-64 Antibody Fab Light Chain 10090
57 5KVF 3 H ZV-64 Antibody Fab Heavy Chain 10090
58 1RUP 1 L immunoglobulin igg2a, heavy chain fab 10090
59 1RUP 2 H immunoglobulin igg2a, light chain fab 10090
60 3ESU 1 F Antibody 14b7* light chain and antibody 14b7* heavy chain linked with a synthetic (GGGGS)4 linker 10090
61 1RUK 1 L immunoglobulin igg2a, light chain fab 10090
62 1RUK 2 H immunoglobulin igg2a, heavy chain fab 10090
63 5VXR 1 H MAb24 Variable Heavy Chain,MAb24 Variable Heavy Chain 10090
64 5VXR 2 L MAb24 Variable Light Chain,MAb24 Variable Light Chain 10090
65 5X08 1 H Fab 4E10 Heavy chain 9606
66 5X08 2 L Fab 4E10 Light chain 9606
67 2X1O 1 A, B GELSOLIN NANOBODY 9844
68 4QGY 1 A, B nanobody n25, VH domain 9844
69 5C2B 1 H scFv 3B4 heavy chain 9606
70 4XAW 1 L 4E10 Fab light chain 9606
71 4XAW 2 H 4E10 Fab heavy chain 9606
72 5VNV 1 A Nb.b201 32630
73 4P49 1 A Antibody scFv B8 9031
74 3N9G 1 H Fab fragment of MAb CR4354, heavy chain 9606
75 3N9G 2 L Fab fragment of MAb CR4354, light chain 9606
76 4TUL 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
77 4TUL 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
78 5DXW 1 A PD-L1 nanobody 10090
79 5UCB 1 H Fab Heavy Chain 9606
80 5UCB 2 L Fab Light Chain 9606
81 2VXV 1 H HUMAN IGG ABT-325 9606
82 2VXV 2 L HUMAN IGG ABT-325 9606
83 4N9O 2 B Nanobody Nb484 Nb484 9844
84 4M3K 2 B Camelid heavy-chain antibody variable fragment cAb-H7S 9844
85 4GXV 1 H, I Antibody 1F1, heavy chain 9606
86 4GXV 2 L, M Antibody 1F1, light chain 9606
87 2VXT 1 H MURINE IGG 125-2H 10090
88 2VXT 3 L MURINE IGG 125-2H 10090
89 1OAQ 1 H HEAVY CHAIN FV, RESIDUES 1-121 10090
90 1T2J 1 A M12-Variable Heavy domain 9606
91 1DLF 2 H ANTI-DANSYL IMMUNOGLOBULIN IGG2A(S) FV FRAGMENT (VH AND VL DOMAINS) 10090
92 6DBF 2 B InlB specific VHH R303 9838
93 6DBG 2 C, D VHH R303 9838
94 1RUM 1 L immunoglobulin igg2a, light chain fab 10090
95 1RUM 2 H immunoglobulin igg2a, heavy chain fab 10090
96 2XA3 1 A LLAMA HEAVY CHAIN ANTIBODY D7 VARIABLE DOMAIN OF A HEAVY CHAIN ANTIBODY 9844
97 2XZA 1 H FAB A.17 HEAVY CHAIN 9606
98 2XZA 2 L FAB A.17 LIGHT CHAIN 9606
99 2W60 1 A ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090
100 2W60 2 B ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090
101 5W24 1 L 5C4 Fab Light Chain 10090
102 5W24 2 H 5C4 Fab Heavy Chain 10090
103 4HPY 1 H CH59 Fab heavy chain 9606
104 4HPY 2 L CH59 Fab light chain 9606
105 3T65 1 B S25-2 FAB (IGG1K) heavy chain 10090
106 3T65 2 A S25-2 FAB (IGG1K) light chain 10090
107 5C6W 1 H, J Protein IGHV1-69-2,Ig lambda chain V-II region NIG-84 9606
108 5VM6 1 A single domain camelid nanobody VHH T10 9844
109 1RJC 1 A camelid heavy chain antibody VHH DOMAIN, VARIABLE DOMAIN 9838
110 4JG1 1 L Fab light chain 9606
111 4JG1 2 H Fab heavy chain 9606
112 3M8O 1 L IMMUNOGLOBULIN A1 LIGHT CHAIN Fab fragment 9606
113 3M8O 2 H IMMUNOGLOBULIN A1 HEAVY CHAIN Fab fragment 9606
114 4KML 2 B Nanobody 9844
115 5VF2 1 A scFv 2D10 10090
116 5I8C 1 A VRC34.01 Fab heavy chain 9606
117 5I8C 2 B VRC34.01 Fab light chain 9606
118 4O5L 1 L Fab F045-092 light chain 9606
119 4O5L 2 H Fab F045-092 heavy chain 9606
120 5MYX 1 A, C Fab c#24 light chain 10090
121 5MYX 2 B, D Fab c#24 heavy chain Pyroglutamate residue 1 (PCA) results from post-translational modification of original residue glutamine 1. 10090
122 4Z9K 2 B VHH2(F5) antibody 30538
123 3IFL 1 L 12A11 FAB antibody light chain 10090
124 3IFL 2 H 12A11 FAB antibody heavy chain 10090
125 5WK2 1 L M116 LIGHT CHAIN 9606
126 5WK2 2 H M116 HEAVY CHAIN FD 9606
127 3PP4 1 H GA101 Fab heavy chain 10090
128 3PP4 2 L GA101 Fab light chain 10090
129 3KDM 1 A, L Immunoglobulin light chain 9606
130 3KDM 2 B, H Immunoglobulin heavy chain 9606
131 5NIV 1 A Light chain of 5D3 Fab 10090
132 5NIV 2 B Heavy chain of 5D3 Fab 10090
133 5N4J 1 L LIGHT CHAIN 9606
134 5N4J 2 H HEAVY CHAIN the sequence provided include the cleavable tag 9606
135 2AJU 1 L ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
136 2AJU 2 H ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
137 2AJV 1 L Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
138 2AJV 2 H Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
139 5X4G 1 A 6H8 Fab heavy chain 10090
140 5X4G 2 B 6H8 Fab light chain 10090
141 3SY0 1 A S25-2 FAB (IGG1K) light chain 10090
142 3SY0 2 B S25-2 FAB (IGG1K) heavy chain 10090
143 1J05 2 B, H anti-CEA mAb T84.66, heavy chain Fv fragment 10090
144 4PTU 1 A Antibody pn132p2C05, light chain 9606
145 4PTU 2 B Antibody pn132p2C05, heavy chain 9606
146 4TPR 1 L If kappa light chain 10090
147 4TPR 2 H Fab heavy chain 10090
148 5LMW 1 A Nanobody 9844
149 4HS6 2 A, L MRCT10.v362 Fab light chain 9606
150 4HS6 3 B, H MRCT10.v362 Fab heavy chain 9606
151 3IFN 1 H 12A11 FAB antibody heavy chain 10090
152 3IFN 2 L 12A11 FAB antibody light chain 10090
153 5U3P 1 H DH511.4 Fab Heavy Chain 9606
154 5U3P 2 L DH511.4 Fab Light Chain 9606
155 6BLA 1 H AMM01 Fab Heavy chain 9606
156 6BLA 2 L AMM01 Fab Light chain 9606
157 5NM0 1 A, B, C, D Nb36 9844
158 4TOY 1 H 35O22 Fab Heavy chain 9606
159 4TOY 2 L 35O22 Fab Light chain 9606
160 4TUO 1 A, C Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
161 4TUO 2 B, D Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
162 3NPS 2 B S4 FAB HEAVY CHAIN 9606
163 3NPS 3 C S4 FAB LIGHT CHAIN 9606
164 5I4F 1 A scFv 2D10 10090
165 1RUR 1 L immunoglobulin 13G5, light chain fab 10090
166 1RUR 2 H immunoglobulin 13G5, heavy chain fab 10090
167 4QXT 1 A Fv fragment(mAb6D8) heavy chain 10090
168 5ADO 1 H FAB A.17 HEAVY CHAIN 9606
169 5ADO 2 L FAB A.17 LIGHT CHAIN 9606
170 5WN9 1 H scFv 2D10 9606
171 4WEM 2 B Anti-F4+ETEC bacteria VHH variable region 9844
172 4XC3 1 L 4E10 Fab light chain 9606
173 4XC3 2 H 4E10 Fab heavy chain 9606
174 1X9Q 1 A 4m5.3 anti-fluorescein single chain antibody fragment antibody binding fragment 9606
175 4PPT 1 A Engineered single domain VHH antibody 9844
176 3R0M 1 A, B Llama VHH A12 9844
177 4M5Y 1 H, I Fab 5J8 heavy chain 9606
178 4M5Y 2 L, M Fab 5J8 light chain 9606
179 4TQE 1 L If kappa light chain 10090
180 4TQE 2 H Fab heavy chain 10090
181 3ZKQ 2 D XA4813 9844
182 5YY4 1 A scFv 4B08 10090
183 4I13 2 B Protein ca1697 (nanobody) 9844
184 4ISV 1 A 1C2 FAB LIGHT CHAIN 10090
185 4ISV 2 B 1C2 FAB HEAVY CHAIN 10090
186 4XC1 1 L 4E10 FAB LIGHT CHAIN 9606
187 4XC1 2 H 4E10 FAB HEAVY CHAIN 9606
188 5C2U 1 B Nanobody Nanobody 9838
189 5VSI 1 H CH1/Ckappa Fab heavy chain 9606
190 5VSI 2 L CH1/Ckappa Fab light chain 9606
191 1XFP 1 A heavy chain antibody VHH domain 9838
192 5ODB 1 A D10 Fab fragment - heavy chain not modeled residues are not visible in the electron density map the Fab fragment was prepared from a antibody chimera containing the variable domains of the human D10 mAb and the constant domains of mouse IgG2a heavy chain and Ig-lambda light chain 9606
193 5ODB 2 B D10 Fab fragment - light chain not modeled residues are not visible in the electron density map the Fab fragment was prepared from a antibody chimera containing the variable domains of the human D10 mAb and the constant domains of mouse IgG2a heavy chain and Ig-lambda light chain 9606
194 4CMH 2 B HEAVY CHAIN OF SAR650984-FAB FRAGMENT 10090
195 4CMH 3 C LIGHT CHAIN OF SAR650984-FAB FRAGMENT 10090
196 5JXA 1 H VRC03 Heavy chain 9606
197 5JXA 2 L VRC03 Light chain 9606
198 3QHZ 1 H, I Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606
199 3QHZ 2 L, M Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606
200 4POY 1 A VHH-metal 9844
201 1A2Y 2 B IGG1-KAPPA D1.3 FV (HEAVY CHAIN) 10090
202 5M2W 1 A, B Llama nanobody nb8 against TssK from T6SS 9844
203 5NLW 1 A nanobody Nb36 9844
204 3UJI 1 L Light chain of anti-HIV-1 V3 monoclonal antibody 2558 9606
205 3UJI 2 H Fab region of the heavy chain of anti-HIV-1 V3 monoclonal antibody 2558 9606
206 3NTC 1 L Fab light chain 10090
207 3NTC 2 H Fab heavy chain 10090
208 2DLF 2 H PROTEIN (ANTI-DANSYL IMMUNOGLOBULIN IGG2A(S) (HEAVY CHAIN)) FV FRAGMENT (VH DOMAIN) SYNONYM: ANTI-DANSYL FV FRAGMENT 10090
209 4YNY 1 A, C Heavy chain of antigen binding fragment, Fab 10116
210 4YNY 2 B, D Light chain of antigen binding fragment, Fab 10116
211 4TUK 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
212 4TUK 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
213 4YO0 1 A, C Heavy chain of antigen binding fragment, Fab 10116
214 4YO0 2 B, D Light chain of antigen binding fragment, Fab 10116
215 1ZVH 2 A Immunoglobulin heavy chain antibody variable domain D2-L24 9838
216 6AZM 1 A, C 580 germline antibody, light chain Fragment: Fab 9606
217 6AZM 2 B, D 580 germline antibody, heavy chain Fragment: Fab 9606
218 6BE3 1 H Fab (F598) Heavy Chain 9606
219 6BE3 2 L Fab (F598) Light Chain 9606
220 2X6M 1 A HEAVY CHAIN VARIABLE DOMAIN FROM DROMEDARY ENGINEERED FROM IMMUNISED DROMEDARY 9838
221 3G9A 2 B Minimizer 9838
222 4NWU 1 H APE1551 Ab Fab heavy chain 9606
223 4NWU 2 L APE1551 Ab Fab light chain 9606
224 3HC4 1 H IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
225 3HC4 2 L IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
226 5VZR 1 A, H G4 antibody heavy chain Fab fragment 10090
227 5VZR 2 B, L G4 antibody light chain Fab fragment 10090
228 2W9D 1 H ICSM 18-ANTI-PRP THERAPEUTIC FAB HEAVY CHAIN 10090
229 2W9D 2 L ICSM 18-ANTI-PRP THERAPEUTIC FAB LIGHT CHAIN 10090
230 5EWI 1 H VRC38.01 Heavy Chain 9606
231 5EWI 2 L VRC38.01 Light Chain 9606
232 5E2W 1 L AT8 LIGHT CHAIN 10090
233 5E2W 2 H AT8 HEAVY CHAIN 10090
234 5MYK 1 A Fab c#17 light chain 10090
235 5MYK 2 B Fab c#17 heavy chain 10090
236 4NZR 1 H PGT135 heavy chain Fab 9606
237 4NZR 2 L PGT135 light chain Fab 9606
238 5MYO 1 A, C Fab c#6 light chain 10090
239 5MYO 2 B, D Fab c#6 heavy chain 10090
240 4HBC 1 H Antigen Binding Fragment, Immunoglobulin IgG - Heavy Chain 9986
241 4HBC 2 L Antigen Binding Fragment, Immunoglobulin IgG - Light Chain 9986
242 4AEH 1 H FAB ANTIBODY, HEAVY CHAIN VARIABLE DOMAIN, RESIDUES 1-231 10090
243 4AEH 2 L FAB ANTIBODY, LIGHT CHAIN VARIABLE DOMAIN, RESIDUES 1-214 10090
244 5UEL 1 H 354NC102 Fab Heavy Chain 9606
245 5UEL 2 L 354NC102 Fab Light Chain 9606
246 3UZQ 1 A anti-dengue Mab 4E11 Single chain variable fragment 10090
247 2V17 2 H MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090
248 2V17 3 L MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090
249 2P43 2 B ANTIBODY CAB-RN05 9838
250 4J6R 2 H HEAVY CHAIN OF ANTIBODY VRC23 9606
251 4J6R 3 L LIGHT CHAIN OF ANTIBODY VRC23 9606
252 5E2V 1 L AT8 LIGHT CHAIN 10090
253 5E2V 2 H AT8 HEAVY CHAIN 10090
254 4KRN 1 A Nanobody/VHH domain EgA1 9844
255 5SY8 1 H 10E8 FAB HEAVY CHAIN 9606
256 5SY8 2 L 10E8 FAB LIGHT CHAIN 9606
257 4GFT 2 B Nanobody 9844
258 4TVS 2 a, b VHH Domain BS-1 30538
259 4W6Y 2 B Nanobody NbFedF9 9844
260 5OCK 1 L Human ACPA E4 Fab fragment - Light chain the N-terminal glutamine is posttranslationally modified to pyroglutamic acid 9606
261 5OCK 2 H Human ACPA E4 Fab fragment - Heavy chain the N-terminal glutamine is posttranslationally modified to pyroglutamic acid 9606
262 6EZW 1 B VHH antibody BCD090-M2 9844
263 5DD1 1 H ANTI-HIV ANTIBODY DH570 FAB HEAVY CHAIN 9544
264 5DD1 2 L ANTI-HIV ANTIBODY DH570 FAB LIGHT CHAIN 9544
265 5JUE 1 L light chain of UIC2 Fab 10090
266 5JUE 2 H heavy chain of UIC2 Fab 10090
267 5CIN 1 H FAB 4E10 HEAVY CHAIN 9606
268 5CIN 2 L FAB 4E10 LIGHT CHAIN 9606
269 1UAC 2 H Ig VH,anti-lysozyme 10090
270 5A2J 1 H SCFV-SM3 CONTAINS BOTH H AND L CHAINS OF SCFV-SM3, CONNECTEDBY A LINKER. CHAIN L RESIDUES ARE NUMBERED FROM 1000. RESIDUES 6-115,20-129 10090
271 5JR1 1 H 10E8 heavy chain 9606
272 5JR1 2 L 10E8 mature light chain 9606
273 4HEM 2 E, F, G Anti-baseplate TP901-1 Llama vHH 02 9844
274 6CA7 1 L PCT64_13C light chain 9606
275 6CA7 2 H PCT64_13C heavy chain 9606
276 5VF6 1 A single chain variable fragment 9031
277 3CFB 1 A, L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090
278 3CFB 2 B, H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090
279 3WII 1 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090
280 3WII 2 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090
281 5OB5 2 H fAb Heavy chain 9606
282 5OB5 3 L fAb Light chain 9606
283 3BKJ 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
284 3BKJ 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
285 5I66 1 A 8B6 antibody, heavy chain 10090
286 5I66 2 B 8B6 antibody, light chain 10090
287 4JAM 1 A, H ANTIGEN BINDING FRAGMENT OF HEAVY CHAIN of CH103 9606
288 4JAM 2 B, L ANTIGEN BINDING FRAGMENT OF LIGHT CHAIN of CH103 9606
289 6BZY 1 H 22D11 Heavy Chain 10090
290 6BZY 2 L 22D11 Light Chain 10090
291 3QQ9 1 C, L 101F LIGHT CHAIN 10090
292 3QQ9 2 D, H 101F HEAVY CHAIN 10090
293 5TKK 2 H mouse antibody vFP5.01 heavy chain 10090
294 5TKK 3 L mouse antibody vFP5.01 light chain 10090
295 5FGB 1 A, B Anti-HCV E2 Fab HC84-1 light chain 9606
296 5FGB 2 C, E Anti-HCV E2 Fab HC84-1 heavy chain 9606
297 4R3S 1 A FV FRAGMENT(MAB6D8) HEAVY CHAIN 10090
298 5W6C 1 H UCA Fab heavy chain 9606
299 5W6C 2 L UCA Fab light chain 9606
300 5M14 2 C, D synthetic Nanobody L2_G11 (a-MBP#2) 32630
301 5I1K 1 L FAB LIGHT CHAIN 9606
302 5I1K 2 H FAB HEAVY CHAIN 9606
303 3OZ9 1 L Fab NC-1 kappa light chain 10090
304 3OZ9 2 H Fab NC-1 IgG2a heavy chain 10090
305 4JDV 1 A, H Fab heavy chain NIH45-46 Germ-line HEAVY CHAIN, IG GAMMA-1 CHAIN 9606
306 4JDV 2 B, L Fab light chain NIH45-46 Germ-line Light CHAIN, IG Kappa 9606
307 5V7U 1 L CBTAU-22.1 Fab light chain 9606
308 5V7U 2 H CBTAU-22.1 Fab heavy chain 9606
309 5UEA 1 A, H Fab Heavy Chain 9606
310 5UEA 3 B, L Fab Light Chain 9606
311 4AL8 2 H FAB 2H12 HEAVY CHAIN 9606
312 4AL8 3 L FAB 2H12 LIGHT CHAIN 9606
313 1YC7 1 A, B anti-VSG immunoglobulin heavy chain variable domain cAbAn33 cAbAn33 9838
314 3G5Y 1 A 175 light chain 10090
315 3G5Y 2 B 175 heavy chain 10090
316 5O02 2 C Nanobody (VHH) Nano-4 30538
317 5NMV 1 L Fab light chain 10088
318 5NMV 2 H Fab heavy chain 10088
319 4N8C 1 H, I Heavy chain of monoclonal antibody 10090
320 4N8C 2 L, M Light chain of monoclonal antibody 10090
321 5AZ2 1 H anti-human epiregulin antibody 9E5 Fab heavy chain 10090
322 5AZ2 2 L anti-human epiregulin antibody 9E5 Fab light chain 10090
323 4HGW 1 A Antibody Fab fragment, light chain 10090
324 4HGW 2 B Antibody Fab fragment, heavy chain 10090
325 1NLB 1 L antibody 19D9D6 light chain 10090
326 1NLB 2 H antibody 19D9D6 heavy chain 10090
327 1KXQ 2 E, F, G, H antibody VHH fragment CABAMD9 9838
328 1C5C 1 L CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 103-214) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-102) IS FROM MURINE SOURCE FAB 10090
329 1C5C 2 H CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 109-230) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-108) IS FROM MURINE SOURCE FAB 10090
330 3VFG 1 L 3F8 Light Chain 10090
331 3VFG 2 H 3F8 Heavy Chain 10090
332 4X7F 2 C, D Nano-25 Nanobody 30538
333 5TDN 1 A, C anti-HER2 Fab Light Chain 9606
334 5TDN 2 B, D anti-HER2 Fab Heavy Chain 9606
335 3QRG 1 L Fab light chain 9606
336 3QRG 2 H Fab heavy chain Fd fragment 9606
337 4UT7 1 H BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11 SCFV HEAVY CHAIN DOMAIN, RESIDUES 1-130 9606
338 5M6A 1 A, B, C, D Bence-Jones light chain 9606
339 4LLY 2 B, D light chain Clambda 9606
340 4LGR 2 B Camelid nanobody (VHH3) 30538
341 4EBQ 1 H anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, heavy chain Fab 10090
342 4EBQ 2 L anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, light chain 10090
343 5EZI 1 H Fab c12 heavy chain 9606
344 5EZI 2 L Fab c12 Light chain 9606
345 4K23 1 H anti-uPAR antibody, heavy chain 10090
346 4K23 2 L anti-uPAR antibody, light chain 10090
347 5J57 2 B VHH single chain antibody V5E1 30538
348 3NCJ 1 L Fab15 Mut8 light chain 9606
349 3NCJ 2 H Fab15 Mut8 heavy chain 9606
350 3UO1 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
351 3UO1 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
352 6BA5 2 B, D, F, H Variable domain Heavy chain, antibody R11 9606
353 4M1G 1 L Murine IgG2a A27D7 Light chain Fab domain 10090
354 4M1G 2 H Murine IgG2a A27D7 Heavy chain Fab domain 10090
355 5W05 1 L M59 FAB LIGHT CHAIN 10090
356 5W05 2 H M59 FAB HEAVY CHAIN FD 10090
357 1MFA 2 H IGG1-LAMBDA SE155-4 FAB (HEAVY CHAIN) 10090
358 2IPU 1 K, L IgG2a Fab fragment Heavy Chain 10090
359 2IPU 2 G, H IgG2a Fab fragment Light Chain Kappa 10090
360 5OMM 2 C Nanobody (VHH) Nano-14 30538
361 5E03 1 A mouse CTLA-4 nanobody 10090
362 3HC3 1 H IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
363 3HC3 2 L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
364 4M61 1 A, C Fab A52 light chain 10090
365 4M61 2 B, D Fab A52 heavy chain 10090
366 5LZ0 1 A, B PorM nanobody 9844
367 3BKM 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
368 3BKM 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
369 1UM5 1 L Antibody 21H3 L chain 10090
370 1UM5 2 H Antibody 21H3 H chain 10090
371 1KXV 2 C, D CAMELID VHH DOMAIN CAB10 9838
372 3QHF 1 H Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606
373 3QHF 2 L Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606
374 4NWT 1 L APE1531 Ab Fab light chain 9606
375 4NWT 2 H APE1531 Ab Fab heavy chain 9606
376 6DBE 1 A, B nanobody VHH R303 9844
377 3WHX 1 A mAb Fab H fragment 10090
378 3WHX 2 B mAb Fab L fragment 10090
379 3NA9 1 L Fab15 light chain 9606
380 3NA9 2 H Fab15 heavy chain 9606
381 3BAE 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
382 3BAE 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
383 1NGZ 1 A Germline Metal Chelatase Catalytic Antibody, Light chain germline Fab fragment 10090
384 1NGZ 2 B Germline Metal Chelatase Catalytic Antibody, Heavy chain germline Fab fragment 10090
385 4LRI 1 A, B MSL-109 Light Chain 9606
386 4LRI 2 C, P MSL-109 Heavy Chain 9606
387 2XXC 1 B CAMELID VHH 9 30538
388 4ZTP 1 L Light chain of Fab fragment of rabbit monoclonal antibody R53 9986
389 4ZTP 2 H Heavy chain of Fab fragment of rabbit monoclonal antibody R53 9986
390 4JN2 1 A, L anti dabigatran Fab 10090
391 4JN2 2 B, H anti dabigatran Fab 10090
392 4XBE 1 L 4E10 FAB LIGHT CHAIN 9606
393 4XBE 2 H 4E10 Fab heavy chain 9606
394 1MJ8 1 L IMMUNOGLOBULIN MS6-126 Fab Fragment, LIGHT CHAIN 10090
395 1MJ8 2 H IMMUNOGLOBULIN MS6-126 Fab Fragment, HEAVY CHAIN 10090
396 6BE2 1 H Fab (F598) Heavy Chain 9606
397 6BE2 2 L Fab (F598) Light Chain 9606
398 3QYC 1 A, B VH domain of IgG molecule 9606
399 4JFZ 1 L Fab light chain 9606
400 4JFZ 2 H Fab heavy chain 9606
401 5VAK 2 B Nb914 Nanobody 9844
402 3WIF 1 A mAb Fab H fragment 10090
403 3WIF 2 B mAb Fab L fragment 10090
404 5U6A 1 A Light Chain 9606
405 5U6A 2 B Heavy Chain 9606
406 5KVD 2 L ZV-2 Antibody Fab Light Chain 10090
407 5KVD 3 H ZV-2 Antibody Fab Heavy Chain 10090
408 3MBX 1 L X836 LIGHT CHAIN 10090
409 3MBX 2 H X836 HEAVY CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN, FD fragment 10090
410 3TWC 1 L PGT127 light chain, Ig lambda-2 chain C regions 9606
411 3TWC 2 H PGT127 heavy chain, Ig gamma-1 chain C region 9606
412 2XXM 2 B CAMELID VHH 9 30538
413 6APC 1 H Epididymis luminal protein 214 9606
414 6APC 2 L IGL@ protein 9606
415 3QXT 1 A, B Anti-Methotrexate CDR1-3 Graft VHH 9844
416 4HHA 1 A Fab KE5 Fab fragment KE5 9606
417 4HHA 2 B Antibody KE5 AD-2S1 eptiope 9606
418 5A2K 1 H IG LAMBDA-1 CHAIN V REGION S43 RESIDUES 6-115,20-129 10090
419 4RGO 2 H 14G8 heavy chain Fab 10090
420 4RGO 3 L 14G8 light chain Fab 10090
421 5N7B 1 H Ig heavy chain V-III region J606,Ig lambda-1 chain V region S43 Please follow the numbering described in the PDB entry 5A2K 10090
422 5GRY 1 A, G diabody 9606
423 5UEK 2 H Fab 12E Heavy Chain 9606
424 5UEK 3 L Fab 12E Light Chain 9606
425 3NAA 1 L Fab15 Mut5 light chain 9606
426 3NAA 2 H Fab15 Mut5 heavy chain 9606
427 6DBD 1 A, B, C, D nanobody VHH R326 9844
428 1Q0X 1 L Fab 9B1, light chain 10090
429 1Q0X 2 H Fab 9B1, heavy chain 10090
430 4R90 1 L Anti CD70 Llama glama Fab 27B3 Light chain 9844
431 4R90 2 H Anti CD70 Llama glama Fab 27B3 Heavy chain 9844
432 4XVT 2 H donor 45 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Heavy chain 9606
433 4XVT 3 L 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Light chain 9606
434 5JDS 1 B Nanobody 9835
435 4OB5 1 H 4E10 antibody germline precursor 7 heavy chain Fv 9606
436 5IK3 1 A, C 1E03 Fab fragment heavy chain 9606
437 5IK3 2 B, D 1E03 Fab fragment light chain 9606
438 5NPH 2 H Heavy chain of Fab fragment derived from non-neutralizing antibody DAO5 10090
439 5NPH 3 L Light chain of Fab fragment derived from non-neutralizing antibody DAO5 10090
440 5XLI 1 a, b FabL 10090
441 5XLI 2 c, d FabH 10090
442 5IHZ 1 A, C, E, H 1E01 Fab fragment heavy chain 9606
443 5IHZ 2 B, D, F, L 1E01 Fab fragment light chain 9606
444 2R1X 1 A Fab, antibody fragment (IgG1k), light chain 10090
445 2R1X 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
446 5U3D 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
447 5U3D 2 B MEMAB TRASTUZUMAB FAB HEAVY CHAIN 9606
448 4WUK 1 H CH65 heavy chain 9606
449 4WUK 2 L CH65 light chain 9606
450 3MLY 1 L, M Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab light chain 9606
451 3MLY 2 H, I Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab heavy chain 9606
452 5U3O 1 H DH511.2_K3 Fab Heavy Chain 9606
453 5U3O 2 L DH511.2_K3 Fab Light Chain 9606
454 1ZVY 1 A Immunoglobulin heavy chain antibody variable domain D3-L11 9838
455 5JOP 1 D, L Fab 14.22 light chain 10090
456 5JOP 2 E, H Fab14.22 heavy chain 10090
457 1U0Q 1 A, B immunoglobulin heavy chain variable domain 9844
458 4HPO 1 H CH58 Fab heavy chain 9606
459 4HPO 2 L CH58 Fab light chain 9606
460 5UKN 1 H DH522UCA Fab fragment heavy chain 9544
461 5UKN 2 L DH522UCA Fab fragment light chain 9544
462 6BHZ 1 H, I Trastuzumab Anti-HER2 Fab Heavy Chain 9606
463 6BHZ 2 L, M Trastuzumab Anti-HER2 Fab Light Chain D185A 9606
464 5L21 2 B VHH-C2 30538
465 5IT2 1 H heavy chain 9606
466 5IT2 2 L light chain 9606
467 4POZ 1 C light chain of Fab fragment of 10B9 antibody 10090
468 4POZ 2 D heavy chain of Fab fragment of 10B9 antibody 10090
469 4F57 1 L Light chain of Fab of a neutralizing antibody L1 light chain of L1 9606
470 4F57 2 H Heavy chain of Fab of a neutralizing antibody L1 heavy chain of L1 9606
471 5FWO 1 A NANOBODY 9844
472 5KVE 3 H ZV-48 Antibody scFv Heavy chain 10090
473 5MO3 2 H Fab of monoclonal antibody, heavy chain 10090
474 5MO3 3 L Fab of monoclonal antibody, light chain 10090
475 1OL0 1 A, B IMMUNOGLOBULIN G VARIABLE HEAVY DOMAIN 9606
476 5GZ0 1 A, C FM329 light chain 1383439
477 5GZ0 2 B, D FM329 heavy chain 1383439
478 3B9V 1 A, B, C, D heavy chain variable domain 9606
479 4W2P 1 A, B, C, D Anti-Marburgvirus Nucleoprotein Single Domain Antibody C 9844
480 1VFA 2 B IGG1-KAPPA D1.3 FV (HEAVY CHAIN) 10090
481 6BQB 1 L MGG4 Fab light chain 9606
482 6BQB 2 H MGG4 Fab heavy chain 9606
483 4PUB 1 H DX-2930 HEAVY CHAIN 9606
484 4PUB 2 L DX-2930 LIGHT CHAIN 9606
485 6B14 1 H Heavy chain of Fab BL3-6S97N 10090
486 6B14 2 L Light chain of Fab BL3-6S97N 10090
487 5N88 1 A, H VH59 antibody 9606
488 5DD6 1 A, H ANTI-HIV ANTIBODY DH570.mut58 FAB HEAVY CHAIN 9544
489 5DD6 2 B, L ANTI-HIV ANTIBODY DH570.mut58 FAB LIGHT CHAIN 9544
490 2D7T 1 H anti polyhydroxybutyrate antibody Fv, heavy chain residues 1-133 9606
491 3WIH 2 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090
492 3WIH 3 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090
493 5GS3 1 A, H diabody protein 9606
494 2OTU 2 B, D, F, H Fv heavy chain variable domain 10090
495 3CFC 1 H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090
496 3CFC 2 L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090
497 6APP 1 A Anti-Marburgvirus Nucleoprotein Single Domain Antibody A 9844
498 3V4U 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
499 3V4U 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
500 5VKD 2 H Fab Heavy Chain 9606
501 5VKD 3 L Fab light chain 9606
502 2R1Y 1 A Fab, antibody fragment (IgG1k), light chain 10090
503 2R1Y 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
504 5XHG 1 A, C polypeptide(L) 562
505 5XHG 2 B, D polypeptide(H) 562
506 4XMP 2 H HEAVY CHAIN OF ANTIBODY VRC08 9606
507 4XMP 3 L LIGHT CHAIN OF ANTIBODY VRC08 9606
508 3UYR 1 H antibody Fab heavy chain 10090
509 3UYR 2 L antibody Fab light chain 10090
510 3V0W 1 L WN1 222-5 Fab (IgG2a) light chain 10090
511 3V0W 2 H WN1 222-5 Fab (IgG2a) heavy chain 10090
512 5OCX 1 L Fab fragment anti-citrullinated protein antibody E4 - light chain N-terminal glutamine is posttranslationally modified to pyroglutamic acid produced as chimera of human E4 mAb variable domains and mouse IgG2a constant domains 9606
513 5OCX 2 H Fab fragment of anti-citrullinated protein antibody E4 - heavy chain unmodelled residues not visible in electron density produced as chimera of human mAb E4 variable domains and mouse IgG2a constant domains 9606
514 1YQV 1 L HyHEL-5 Antibody Light Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090
515 1YQV 2 H HyHEL-5 Antibody Heavy Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090
516 3OAZ 1 H, M Fab 2G12, heavy chain Fab 9606
517 3OAZ 2 K, L Fab 2G12, light chain 9606
518 2R2B 1 A Fab, antibody fragment (IgG1k), light chain 10090
519 2R2B 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
520 1ZAN 1 L Fab AD11 Light Chain 10116
521 1ZAN 2 H Fab AD11 Heavy Chain 10116
522 6CJK 1 A, C Immunoglobulin Fab light chain 9986
523 6CJK 2 B, D Immunoglobulin Fab heavy chain 9986
524 4N0Y 1 H IGH526 Heavy Chain 9606
525 4N0Y 2 L IGH526 Light Chain 9606
526 3V52 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
527 3V52 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
528 5MTH 1 A, H antibody Fab heavy chain 10090
529 5MTH 2 B, L antibody Fab light chain 10090
530 3GGW 1 A, C FAB F22-4 LIGHT CHAIN 10090
531 3GGW 2 B, D FAB F22-4 HEAVY CHAIN 10090
532 2E27 2 H anti-ciguatoxin antibody, heavy chain Fv fragment 10090
533 1RZF 1 L Fab E51 light chain 9606
534 1RZF 2 H Fab E51 heavy chain 9606
535 4KTE 1 H GE148 Heavy Chain Fab Fab fragment 9544
536 4KTE 2 L GE148 Light Chain Fab 9544
537 5I8O 1 H HMM5 antibody heavy chain 9606
538 5I8O 2 L HMM5 antibody light chain 9606
539 4OUO 1 A anti Bla g 1 scFv 9031
540 4JG0 1 L Fab light chain 9606
541 4JG0 2 H Fab heavy chain 9606
542 4YGV 1 A, F aDabi-Fab2a heavy chain 9606
543 4YGV 2 B, L aDabi-Fab2a light chain 9606
544 5U4R 1 A, H VRC 315 53-1A09 Fab Heavy chain 9606
545 5U4R 2 B, L VRC 315 53-1A09 Fab Light chain 9606
546 5ALC 1 H ANTI-TICAGRELOR FAB 72, HEAVY CHAIN 9606
547 5ALC 2 L ANTI-TICAGRELOR FAB 72, LIGHT CHAIN 9606
548 5U5F 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
549 5U5F 2 B MEMAB TRASTUZUMAB FAB HEAVY CHAIN 9606
550 3EO0 1 A, C GC-1008 Fab Light Chain 10090
551 3EO0 2 B, D GC-1008 Fab Heavy Chain 10090
552 5CIL 1 H FAB 4E10 HEAVY CHAIN 9606
553 5CIL 2 L FAB 4E10 LIGHT CHAIN 9606
554 6BI2 1 H, I Trastuzumab Anti-HER2 Fab Heavy Chain 9606
555 6BI2 2 L, M Trastuzumab Anti-HER2 Fab Light Chain 9606
556 5F3B 1 A, E RK35 Chimeric antibody heavy chain 10090
557 5F3B 2 B, F RK35 Chimeric antibody light chain 10090
558 4POU 2 B VHH Antibody 9844
559 1MVF 1 A, B immunoglobulin heavy chain variable region 9838
560 4FQI 3 H antibody CR9114 heavy chain Fab 9606
561 4FQI 4 L antibody CR9114 light chain Fab Lambda 9606
562 4JVP 1 A, B Anti-HCV E2 alpaca nanobody D03 30538
563 3QSK 2 B Engineered 5 Histidine anti-RNase A Camelid VHH Antibody Domain Variant 9838
564 4JHA 1 H D25 antigen-binding fragment heavy chain 9606
565 4JHA 2 L D25 light chain 9606
566 3MCL 1 L C706 MONOCLONAL LIGHT CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
567 3MCL 2 H C706 MONOCLONAL HEAVY CHAIN FD fragment of the heavy chain, CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
568 4PTT 1 A Antibody pn132p2C05, light chain 9606
569 4PTT 2 B Antibody pn132p2C05, heavy chain 9606
570 5OD0 1 L Fab fragment of ACPA E4 - Light chain the Fab fragment was prepared from a chimeric antibody containing the variable domain of human ACPA E4 and constant domains of mouse IgG2b the N-terminal Gln is posttranslationally modified to pyroglutamic acid 2 C-terminal residues not visible in electron density and therefore not modelled 9606
571 5OD0 2 H Fab fragment of ACPA E4 - heavy chain the Fab fragment was prepared from a chimeric antibody containing the variable domain of human ACPA E4 and constant domains of mouse IgG2b the N-terminal Gln is posttranslationally modified to pyroglutamic acid residues not modeled are not visible in the electron density map 9606
572 4EJ1 2 C, D Nb113 camelid antibody fragment 9844
573 5KVL 1 H Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) heavy chain Fab fragment 9606
574 5KVL 2 L Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) light chain 9606
575 5TDO 1 A, C anti-HER2 Fab Light Chain 9606
576 5TDO 2 B, D anti-HER2 Fab Heavy Chain 9606
577 2P42 2 B, D ANTIBODY CAB-RN05 9838
578 8FAB 1 A, C IGG1-LAMBDA HIL FAB (LIGHT CHAIN) 9606
579 8FAB 2 B, D IGG1-LAMBDA HIL FAB (HEAVY CHAIN) 9606
580 5NHW 1 H anti-human ActRII Bimagrumab Fab heavy-chain C-terminal FLAG-His6 tag Fab heavy-chain 9606
581 5NHW 2 L anti-human ActRII Bimagrumab Fab light-chain Fab light-chain 9606
582 2ZPK 1 L, M IgG1-lambda P20.1 Fab (light chain) 10090
583 2ZPK 2 H, I IgG1-lambda P20.1 Fab (heavy chain) Variable and Constant region 10090
584 4DGV 1 H HCV1 Heavy Chain Fab 9606
585 4DGV 2 L HCV1 Light Chain 9606
586 2DQU 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
587 2DQU 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
588 5TH2 1 A, C cetuximab Fab, light chain 10090
589 5TH2 2 B, D cetuximab Fab, heavy chain 10090
590 1I8K 2 B EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY MR1SCFV HEAVY CHAIN 10090
591 5I8K 1 L HHH1 Fab Light chain 9606
592 5I8K 2 H HHH1 Fab Heavy chain 9606
593 4QLR 1 A, B Llama nanobody n02 VH domain 9844
594 5J56 2 B VHH single chain antibody V1C7 30538
595 4YDL 2 B, H HEAVY CHAIN OF ANTIBODY C38-VRC18.02 9606
596 4YDL 3 C, L LIGHT CHAIN OF ANTIBODY C38-VRC18.02 9606
597 3T4Y 1 A S25-2 FAB (IGG1K) LIGHT CHAIN 10090
598 3T4Y 2 B S25-2 FAB (IGG1K) HEAVY CHAIN 10090
599 1YNL 1 L Ig gamma light chain 10090
600 1YNL 2 H Ig gamma heavy chain 10090
601 5EPM 1 A, E Antibody Fab fragment heavy chain 10090
602 5EPM 2 B, F Antibody Fab fragment light chain 10090
603 2AJS 1 L Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 kappa light chain 10090
604 2AJS 2 H Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
605 3UMT 1 A scFv heavy chain and light chain 10090
606 3BZ4 1 A, C, E, G Fab F22-4 light chain 10090
607 3BZ4 2 B, D, F, H Fab F22-4 heavy chain 10090
608 4NUJ 1 A PGT152 light chain 9606
609 4NUJ 2 B PGT152 heavy chain 9606
610 3LIZ 2 L 4C3 monoclonal antibody Light Chain 10090
611 3LIZ 3 H 4C3 monoclonal antibody Heavy Chain 10090
612 1RUA 1 L immunoglobulin igg2a, light chain fab 10090
613 1RUA 2 H immunoglobulin igg2a, heavy chain fab 10090
614 3U2S 1 A, H PG9 heavy chain antigen-binding fragment 9606
615 3U2S 2 B, L PG9 light chain 9606
616 5D6C 1 A, L 4497 antibody IgK (VL and CL) 9606
617 5D6C 2 B, H 4497 antibody IgG1 (VH and CH1) 9606
618 4GAG 1 H NEUTRALIZING ANTIBODY AP33 HEAVY CHAIN 10090
619 4GAG 2 L NEUTRALIZING ANTIBODY AP33 LIGHT CHAIN 10090
620 2R23 1 A Fab, antibody fragment (IgG1k), light chain 10090
621 2R23 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
622 4NUG 1 L PGT151 light chain 9606
623 4NUG 2 H PGT151 heavy chain 9606
624 3IU4 1 H chP3 Fab heavy chain 10090
625 3IU4 2 L chP3 Fab light chain 10090
626 3MNZ 2 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN mouse Fv,human Fc 10090
627 3MNZ 3 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN mouse Fv,human Fc 10090
628 3MLR 1 L Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab light chain 9606
629 3MLR 2 H Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab heavy chain 9606
630 1QYG 1 L FAB M82G2, LIGHT CHAIN 10090
631 1QYG 2 H FAB M82G2, HEAVY CHAIN 10090
632 1P7K 1 A, L antibody light chain FAB 10090
633 1P7K 2 B, H antibody heavy chain FAB 10090
634 4NBX 2 B A20.1 VHH 9844
635 1G7J 2 B ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 HEAVY CHAIN 10090
636 3RVV 2 C 4C1 - light chain 10090
637 3RVV 3 D 4C1 - heavy chain 10090
638 4HEP 2 G vHH17 domain 9844
639 5A2L 1 H SCFV-SM3 RESIDUES 6-115,20-129 10090
640 3P0Y 2 H Fab DL11 heavy chain 9606
641 3P0Y 3 L Fab DL11 light chain 9606
642 4NPY 1 A, L germline PGT121 light chain Fab 9606
643 4NPY 2 B, H germline PGT121 heavy chain Fab 9606
644 6ANA 2 H LL2 Fab Heavy Chain 10090
645 6ANA 3 L LL2 Fab Light Chain 10090
646 5IBU 1 B, L 6652 Light Chain 9606
647 5IBU 2 G, H 6652 Heavy Chain 9606
648 5VPL 2 C 4C1 - LIGHT CHAIN 10090
649 5VPL 3 D 4C1 - HEAVY CHAIN 10090
650 6AOD 1 A FXIa Antibody FAB Light Chain 9606
651 6AOD 2 B FXIa Antibody FAB Heavy Chain 9606
652 5WCD 1 H VRC315 04-1D02 Fab Heavy chain 9606
653 5WCD 2 L VRC315 04-1D02 Fab Light chain 9606
654 2YPV 2 H FAB 12C1 10090
655 2YPV 3 L FAB 12C1 10090
656 3QXU 1 A, B, C, D Anti-Methotrexate CDR1-3 Graft 9844
657 4HH9 1 A, C Fab KE5, light chain KE5 Light chain 9606
658 4HH9 2 B, D Fab KE5, heavy chain KE5 Heavy Chain 9606
659 4JY5 1 L PGT122 light chain Fab 9606
660 4JY5 2 H PGT122 heavy chain Fab 9606
661 6ELE 1 A, H fAB heavy chain 9606
662 6ELE 2 B, L fAB light chain 9606
663 1VFB 2 B IGG1-KAPPA D1.3 FV (HEAVY CHAIN) 10090
664 5UR8 1 A human immunoglobulin gamma, heavy chain Fd fragment 9606
665 5UR8 2 B human immunoglobulin gamma, kappa light chain 9606
666 6B5R 1 H CIS42 Fab Heavy chain 9606
667 6B5R 2 L CIS42 Fab Light chain 9606
668 5IML 2 B Nanobody 9835
669 3NAC 1 L Fab15 Mut7 light chain 9606
670 3NAC 2 H Fab15 Mut7 heavy chain 9606
671 3A6C 2 H IG VH, anti-lysozyme 10090
672 2DQD 2 H Ig VH,anti-lysozyme 10090
673 1HCV 1 A IMMUNOGLOBULIN G FROM IMMUNIZED LLAMA HEAVY CHAIN VARIABLE DOMAIN FROM LLAMA 9844
674 5U5M 1 A MEMAB TRASTUZUMAB, LIGHT CHAIN 9606
675 5U5M 2 B MEMAB TRASTUZUMAB, HEAVY CHAIN 9606
676 2DQT 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
677 2DQT 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
678 1Q72 1 L Fab M82G2, Light chain 10090
679 1Q72 2 H Fab M82G2, Heavy chain 10090
680 4M1D 1 L, M Fab mAb 447-52D Light Chain 9606
681 4M1D 2 H, I Fab mAb 447-52D Heavy Chain 9606
682 1SEQ 1 L Monoclonal Antibody MNAC13 FAB Light Chain 10090
683 1SEQ 2 H Monoclonal Antibody MNAC13 FAB Heavy Chain 10090
684 1G7I 2 B ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 HEAVY CHAIN 10090
685 4YHO 1 H aDabi-Fab3 heavy chain 9606
686 4YHO 2 L aDabi-Fab3 light chain 9606
687 2R1W 1 A Fab, antibody fragment (IgG1k), light chain 10090
688 2R1W 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
689 3MO1 1 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090
690 3MO1 2 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090
691 4DGY 1 H HCV1 Heavy Chain Fab 9606
692 4DGY 2 L HCV1 Light Chain 9606
693 3A67 2 H IG VH, anti-lysozyme 10090
694 1RI8 1 A camelid ANTIBODY HEAVY CHAIN VHH domain, VARIABLE DOMAIN 9838
695 5EN2 1 A GD01 heavy chain 10090
696 5EN2 2 B GD01 light chain 10090
697 3T77 1 A S25-2 FAB (IGG1K) light chain 10090
698 3T77 2 B S25-2 FAB (IGG1K) heavy chain 10090
699 1J1X 2 H Ig VH,anti-lysozyme 10090
700 5M2J 2 D Anti-(ED-B) scFV 9606
701 3MXW 2 L 5E1 light chain 9606
702 3MXW 3 H 5E1 heavy chain 9606
703 2V7N 1 A, C, E, G IMMUNOGLOBULIN LIGHT CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-255 32630
704 2V7N 2 B, D, F, H IMMUNOGLOBULIN HEAVY CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-259 32630
705 2DQC 2 H Ig VH,anti-lysozyme 10090
706 1J1O 2 H Ig VH,anti-lysozyme 10090
707 3EO9 1 L Efalizumab Fab fragment, light chain 9606
708 3EO9 2 H Efalizumab Fab fragment, heavy chain 9606
709 1MVU 2 B Ig VDJ-region (HEAVY CHAIN) LIGHT AND HEAVY CHAINS LINKED WITH A SYNTHETIC (GGGGS)3 LINKER 10090
710 4M62 2 H, I GEP2 FV heavy chain 9606
711 4ALA 2 H FAB 2H12 HEAVY CHAIN 10090
712 4ALA 3 L FAB 2H12 LIGHT CHAIN 10090
713 5IVO 1 A BC2-nanobody 30538
714 1J1P 2 H Ig VH,anti-lysozyme 10090
715 4F33 1 A, C, E, G MORAb-009 FAB light chain 10090
716 4F33 2 B, D, F, H MORAb-009 FAB heavy chain 10090
717 4NBZ 2 B, D A26.8 VHH 9844
718 3C6S 1 A, C, E, G Fab F22-4 light chain 10090
719 3C6S 2 B, D, F, H Fab F22-4 heavy chain 10090
720 5WUV 1 L light chain 9606
721 5WUV 2 H heavy chain 9606
722 4Z8F 1 H S1-15 Fab (IgG2b) heavy chain 10090
723 4Z8F 2 L S1-15 Fab (IgG2b kappa) light chain 10090
724 3OKL 1 A S25-39 Fab (IgG1k) light chain 10090
725 3OKL 2 B S25-39 Fab (IgG1k) heavy chain 10090
726 5AYU 2 H Ig VH,anti-lysozyme 10090
727 4JM4 1 H PGT 135 Heavy Chain Fab 9606
728 4JM4 2 L PGT 135 Light Chain Fab 9606
729 2HWZ 1 L Immunoglobulin Fab light chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
730 2HWZ 2 H Immunoglobulin Fab heavy chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
731 3A6B 2 H IG VH, anti-lysozyme 10090
732 2DQJ 2 H Ig VH,anti-lysozyme 10090
733 5F21 2 B nanobody MU375 9844
734 1N4X 2 H, I immunoglobulin heavy chain variable region 10090
735 6B0G 1 C 1245 Antibody, Light Chain 9606
736 6B0G 2 D 1245 Antibody, Heavy Chain 9606
737 5TDP 1 A, C anti-HER2 Fab Light Chain 9606
738 5TDP 2 B, D anti-HER2 Fab Heavy Chain 9606
739 1ZEA 1 L monoclonal anti-cholera toxin IGG1 KAPPA antibody, L chain 10090
740 1ZEA 2 H monoclonal anti-cholera toxin IGG1 KAPPA antibody, H chain 10090
741 6D0X 1 A 2140 Antibody, heavy chain 9606
742 6D0X 2 B 1210 Antibody, light chain 9606
743 2P44 2 B ANTIBODY CAB-RN05 9838
744 6BE4 1 H Fab (F598) Heavy Chain 9606
745 6BE4 2 L Fab(F598) Light Chain 9606
746 5TPP 1 L DH270.5 Fab heavy chain 9606
747 5TPP 2 H DH270.5 Fab light chain 9606
748 5L88 1 H Anti-afamin antibody N14, Fab fragment, heavy chain 10090
749 5L88 2 L Anti-afamin antibody N14, Fab fragment, light chain 10090
750 1KIQ 2 B MONOCLONAL ANTIBODY D1.3 10090
751 1Q9W 1 A, C S45-18 Fab (IgG1k) light chain Fab1 Light chain kappa 10090
752 1Q9W 2 B, D S45-18 Fab (IgG1k) heavy chain Fab1 Heavy chain g1 10090
753 4P3C 1 H Heavy Chain Fab fragment of antibody LEM-2/15 MT1-MMP V-B loop 10090
754 4P3C 2 L Light Chain Fab fragment of antibody LEM-2/15 10090
755 5TP3 1 A, B F-VHH-4 9844
756 1L7I 1 L chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence light chain (residues 1-214) 9606
757 1L7I 2 H chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence heavy chain (residues 1-216) 9606
758 1JPT 1 L immunoglobulin Fab D3h44, light chain Fab fragment 9606
759 1JPT 2 H immunoglobulin Fab D3H44, heavy chain Fab fragment 9606
760 1AQK 1 L FAB B7-15A2 IMMUNOGLOBULIN HUMAN FAB FAB 9606
761 1AQK 2 H FAB B7-15A2 IMMUNOGLOBULIN HUMAN FAB FAB 9606
762 5TL5 1 L M2177 LIGHT CHAIN 10090
763 5TL5 2 H M2177 HEAVY CHAIN 10090
764 2FX7 1 L Fab 4E10 Light Chain 9606
765 2FX7 2 H Fab 4E10 Heavy Chain 9606
766 5Y9K 1 L belimumab light chain 9606
767 5Y9K 2 H belimumab heavy chain 9606
768 4DTG 1 L Humanized recombinant FAB fragment, FAB 2021, of a murine antibody, light chain 9606
769 4DTG 2 H Humanized recombinant FAB fragment, FAB 2021, of a murine antibody, heavy chain 9606
770 5E0Q 1 A Anti-Nup98 Nanobody TP377 30538
771 5CSZ 1 A, H GANTENERUMAB FAB FRAGMENT HEAVY CHAIN FAB 9606
772 5CSZ 2 B, L GANTENERUMAB FAB FRAGMENT LIGHT CHAIN FAB 9606
773 4LHJ 2 B Camelid antibody 30538
774 3WFH 1 A mAb Fab H fragment 10090
775 3WFH 2 B mAb Fab L fragment 10090
776 4BEL 2 D, E XA4813 9844
777 5M7Q 1 A, B Nanobody NbD2 9838
778 5H8D 1 A VHH nanobody 9844
779 3LN9 1 A Immunoglobulin heavy chain antibody variable domain B10 9835
780 4K3D 1 H, I BOVINE ANTIBODY WITH ULTRALONG CDR H3, HEAVY CHAIN 9913
781 4K3D 2 L, M BOVINE ANTIBODY WITH ULTRALONG CDR H3, LIGHT CHAIN 9913
782 4H8W 2 H FAB HEAVY CHAIN OF ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ANTIBODY N5-I5 9606
783 4H8W 3 L FAB LIGHT CHAIN OF ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ANTIBODY N5-I5 9606
784 3HNT 1 H CS-35 Fab Heavy Chain Heavy Chain 10090
785 3HNT 2 L CS-35 Fab Light Chain Light Chain 10090
786 5IP4 1 A, B XA4551 NANOBODY AGAINST C-DCX 9844
787 3DUR 2 B, D Ig-like protein 10090
788 1WEJ 1 L E8 ANTIBODY IGG1 KAPPA MOUSE MONOCLONAL ANTIBODY FAB 10090
789 1WEJ 2 H E8 ANTIBODY IGG1 KAPPA MOUSE MONOCLONAL ANTIBODY FAB 10090
790 5VPG 2 C FAB 4C1 - LIGHT CHAIN 10090
791 5VPG 3 D FAB 4C1 - HEAVY CHAIN 10090
792 5HI4 2 C, H CAT-2000 FAB heavy chain 9606
793 5HI4 3 D, L CAT-2000 FAB light chain 9606
794 5NUZ 1 A, H eOD01 heavy chain Fab fragment (domains: variable heavy and constant heavy 1) Fab fragment (domains: variable heavy and constant heavy 1) 10090
795 5NUZ 2 B, L eOD01 light chain Fab fragment (domains: variable light and constant light) Fab fragment (domains: variable light and constant light) 10090
796 5FCU 2 H JR4 FAB HEAVY CHAIN 9544
797 5FCU 3 L JR4 FAB LIGHT CHAIN 9544
798 3RVW 2 C 4C1 - light chain 10090
799 3RVW 3 D 4C1 - heavy chain 10090
800 5DD3 1 H ANTI-HIV ANTIBODY DH570.4 FAB HEAVY CHAIN 9544
801 5DD3 2 L ANTI-HIV ANTIBODY DH570.4 FAB LIGHT CHAIN 9544
802 5XKU 2 B HNIgGA6 light chain 9606
803 5XKU 3 C HNIgGA6 heavy chain 9606
804 3D85 1 A FAB of antibody 7G10, light chain light chain 9606
805 3D85 2 B FAB of antibody 7G10, heavy chain heavy chain 9606
806 4Z95 1 H S1-15 Fab (IgG2b) heavy chain 10090
807 4Z95 2 L S1-15 Fab (IgG2b) light chain 10090
808 5HI5 2 C, H CAT-2000 FAB heavy chain 9606
809 5HI5 3 D, L CAT-2000 light chain 9606
810 5JO5 1 A, C, E, H 10E8 gHV 9606
811 5JO5 2 B, D, F, L 10E8 gLV 9606
812 5L9D 1 H MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA HEAVY CHAIN 10090
813 5L9D 2 L MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA LIGHT CHAIN 10090
814 2XV6 2 B, D CAMELID VHH 9 30538
815 4QO1 1 A Nb139 Nanobody against the DNA-binding domain of p53 9844
816 5CCK 1 H Antibody 3BC315 Fab heavy chain 9606
817 5CCK 2 L Antibody 3BC315 Fab light chain 9606
818 5VM0 1 A, B Camelid Nanobody VHH T9 9844
819 5I76 1 A, C FM318_light_chain 1383439
820 5I76 2 B, D FM318_heavy_cahin 1383439
821 1KCV 1 L PC282 IMMUNOGLOBULIN light chain 10090
822 1KCV 2 H PC282 IMMUNOGLOBULIN heavy chain 10090
823 1FLR 1 L 4-4-20 (IG*G2A=KAPPA=) FAB FRAGMENT 10090
824 1FLR 2 H 4-4-20 (IG*G2A=KAPPA=) FAB FRAGMENT 10090
825 5I18 1 L FAB LIGHT CHAIN 9606
826 5I18 2 H FAB HEAVY CHAIN 9606
827 4JN1 1 H anti-dabigatran Fab1, heavy chain 10090
828 4JN1 2 L anti-dabigatran Fab1, light chain 10090
829 4ZG1 1 A, B, C, D, E, F NB17 9844
830 4P3D 1 A, H Heavy Chain Fab fragment of antibody LEM-2/15 10090
831 4P3D 2 B, L Light Chain Fab fragment of antibody LEM-2/15 10090
832 4G5Z 1 H canakinumab antibody fragment heavy chain 9606
833 4G5Z 2 L canakinumab antibody fragment light chain 9606
834 3TNM 1 A, H Fab heavy chain of human anti-HIV-1 Env antibody A32 9606
835 3TNM 2 B, L Fab light chain of human anti-HIV-1 Env antibody A32 9606
836 2OK0 2 L Fab ED10 light chain 10090
837 2OK0 3 H Fab ED10 heavy chain 10090
838 6BAN 2 B, D, F, H Variable domain R11 Heavy chain 9606
839 3SOB 1 L antibody light chain 9606
840 3SOB 3 H antibody heavy chain 9606
841 6B5M 1 H CIS43 Fab Heavy chain 9606
842 6B5M 2 L CIS43 Fab Light chain 9606
843 4I1N 2 B Protein ca1697 (nanobody) 9844
844 5AWN 1 H Heavy chain of 3BC176 Fab 9606
845 5AWN 2 L Light chain of 3BC176 Fab 9606
846 4ZFO 2 L J22.9-xi Fab, Light Chain Fab Light Chain fragment of anti-BCMA antibody J22.9-xi 10090
847 4ZFO 3 A, H J22.9-xi Fab, Heavy Chain Fab Heavy Chain fragment of anti-BCMA antibody J22.9-xi 10090
848 4ZFO 4 B J22.9-xi Fab, Light Chain Fab Light Chain fragment of anti-BCMA antibody J22.9-xi 10090
849 4G6M 2 H heavy chain of gevokizumab antibody binding fragment 10090
850 4G6M 3 L light chain of gevokizumab antibody binding fragment 10090
851 5DR5 1 H AbD09097 Fab heavy chain The Fab heavy chain contains a C-terminal Myc- and hexahistidine extension preceded by thrombin peptidase recognition sequence to facilitate detection and purification 9606
852 5DR5 2 L AbD09097 Fab light chain 9606
853 3QXW 1 A, B, C, D, E Anti-Methotrexate CDR1-4 Graft VHH 9844
854 2IH3 1 A FAB Heavy Chain 10090
855 2IH3 2 B FAB Light Chain 10090
856 4KQ3 1 L CNTO3186 light chain Fab 9606
857 4KQ3 2 H CNTO3186 heavy chain Fab 9606
858 6F0D 1 A, B VHH antibody BCD090-M2 9844
859 6AQ7 2 H POM6 FAB Heavy CHAIN 10090
860 6AQ7 3 L POM6 FAB light CHAIN 10090
861 4JFX 1 A, L Fab light chain 9606
862 4JFX 2 B, H Fab heavy chain 9606
863 3SGE 1 I, L Light Chain 10090
864 3SGE 2 H, J Heavy Chain 10090
865 1BM3 1 L IMMUNOGLOBULIN OPG2 FAB, CONSTANT DOMAIN CONSTANT DOMAIN 10090
866 1BM3 2 H IMMUNOGLOBULIN OPG2 FAB, VARIABLE DOMAIN VARIABLE DOMAIN 10090
867 4TUJ 1 A, C Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
868 4TUJ 2 B, D Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
869 2VXQ 2 H FAB H CHAIN OF THE FAB FRAGMENT COMPOSED OF THE IGE VARIABLE DOMAIN AND IGG CONSTANT DOMAIN 9606
870 2VXQ 3 L FAB L CHAIN OF THE FAB FRAGMENT COMPOSED OF THE IGE VARIABLE DOMAIN AND IGG CONSTANT DOMAIN 9606
871 2XWT 1 A THYROID BLOCKING HUMAN AUTOANTIBODY K1-70 HEAVY CHAIN FAB FRAGMENT HEAVY CHAIN, RESIDUES 1-229 9606
872 2XWT 2 B THYROID BLOCKING HUMAN AUTOANTIBODY K1-70 LIGHT CHAIN FAB FRAGMENT LIGHT CHAIN, RESIDUES 1-213 9606
873 5FHB 1 H Antibody 100 Fab heavy chain 9606
874 5FHB 2 L Antibody 100 Fab light chain 9606
875 3HZM 1 A S73-2 Fab (IgG1k) light chain 10090
876 3HZM 2 B S73-2 Fab (IgG1k) heavy chain 10090
877 1JGU 1 L Antibody Light Chain 10090
878 1JGU 2 H Antibody Heavy Chain 10090
879 4I77 1 H Lebrikizumab heavy chain Fab 9606
880 4I77 2 L Lebrikizumab light chain Fab 9606
881 4OCR 1 L CAP256-VRC26.01 light chain Fab 9606
882 4OCR 2 H CAP256-VRC26.01 heavy chain Fab 9606
883 4O4Y 1 L 2095-2 light chain SEE REMARK 999 9986
884 4O4Y 2 H 2095-2 heavy chain 9986
885 1FGV 2 H H52 FV (HEAVY CHAIN) 9606
886 5OBF 1 H fAb Heavy chain 10090
887 5OBF 2 L fAb Light chain 10090
888 5LGH 1 H MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA HEAVY CHAIN IGG1-KAPPA HEAVY CHAIN, 1-214 10090
889 5LGH 2 L MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA LIGHT CHAIN IGG1-KAPPA LIGHT CHAIN, 1-214 10090
890 1UZ8 1 A, L IGG FAB (IGG3, KAPPA) LIGHT CHAIN 291-2G3-A FAB FRAGMENT LIGHT CHAIN, RESIDUES 1-212 10090
891 1UZ8 2 B, H IGG FAB (IGG3, KAPPA) HEAVY CHAIN 291-2G3-A FAB FRAGMENT HEAVY CHAIN, RESIDUES 1-213 10090
892 1DQQ 1 A, C ANTI-LYSOZYME ANTIBODY HYHEL-63 (LIGHT CHAIN) FAB FRAGMENT 10090
893 1DQQ 2 B, D ANTI-LYSOZYME ANTIBODY HYHEL-63 (HEAVY CHAIN) FAB FRAGMENT 10090
894 5L7X 1 H Mouse Antibody Fab Fragment, IgG1-kappa Heavy Chain IgG1-kappa heavy chain, 1-214 10090
895 5L7X 2 L Mouse Antibody Fab Fragment, IgG1-kappa Light Chain IgG1-kappa light chain, 1-214 10090
896 5V6M 1 L Light chain of Fab fragment of rabbit anti-HIV1 gp120 V3 mAb 10A3 9986
897 5V6M 2 H Heavy chain of Fab fragment of rabbit anti-HIV1 gp120 V3 mAb 10A3 9986
898 5MHE 1 L Fab-fragment 10090
899 5MHE 2 H Fab-fragment 10090
900 4GLR 2 H, J anti-ptau heavy chain heavy chain 9031
901 4GLR 3 I, K anti-ptau light chain light chain 9031
902 5WK3 1 P, R, T, V M116 LIGHT CHAIN 9606
903 5WK3 2 Q, S, U, W M116 HEAVY CHAIN FD 9606
904 4HJG 1 A Trastuzumab light chain 9606
905 4HJG 2 B Trastuzumab heavy chain 9606
906 4LCI 2 H anti canine CD28 antibody, 1C6, heavy chain 10090
907 5OWP 1 H Ig heavy chain V-III region J606,Ig lambda-1 chain V region H2020 10090
908 4M43 1 L Fragment antigen-binding 523-11 light chain 10090
909 4M43 2 H Fragment antigen-binding 523-11 heavy chain 10090
910 5I30 1 L Fab PL-2 light chain 10090
911 5I30 2 H Fab PL-2 heavy chain 10090
912 4W6X 2 B Nanobody NbFedF7 9844
913 3HC0 1 A, H IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
914 3HC0 2 B, L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
915 3BKC 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
916 3BKC 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
917 3FN0 1 L Fab Z13e1 light chain 9606
918 3FN0 2 H Fab Z13e1 heavy chain 9606
919 5X5X 1 H Fd chain of anti-osteocalcin antibody KTM219 10090
920 5X5X 2 L L chain of anti-osteocalcin antibody KTM219 10090
921 4YHI 1 A, H aDabi-Fab2a heavy chain 9606
922 4YHI 2 B, L aDabi-Fab2a light chain 9606
923 5NYX 1 H, M, O HEAVY CHAIN CHAIN H AND O ARE TWO SEPARATE POLYPEPTIDE CHAINS. fab heavy chains. The sequence provided contains the cleavable strep tag that has been removed prior to crystallisation 9606
924 5NYX 2 L, N, P LIGHT CHAIN fab light chain 9606
925 4OSU 1 H SM5-1 Fab Heavy Chain 9606
926 4OSU 2 L SM5-1 Fab Light Chain 9606
927 5JA9 2 A, B Nanobody 6 9844
928 3MXV 1 L fab fragment of anti-Shh 5E1 mouse/human chimera, light chain 10090
929 3MXV 2 H fab fragment of anti-Shh 5E1 mouse/human chimera, heavy chain 10090
930 5IFA 1 H VRC01c-HuGL2 Fab heavy chain 9606
931 5IFA 2 L VRC01c-HuGL2 Fab light chain 9606
932 1A7N 2 H IGG1-KAPPA D1.3 FV (HEAVY CHAIN) FV FRAGMENT 10090
933 1T2Q 1 L Fab NNA7 Heavy Chain 10090
934 1T2Q 2 H Fab NNA7 Light Chain 10090
935 6ELJ 1 A, H fAB heavy chain 9606
936 6ELJ 2 B, L fAB light chain 9606
937 4G6K 1 H heavy chain of gevokizumab antibody binding fragment 10090
938 4G6K 2 L light chain of gevokizumab antibody binding fragment 10090
939 1JTP 1 A, B Single-Domain Antibody VH DOMAIN FRAGMENT 9838
940 4MAU 1 L C2244 light chain SEE REMARK 999 10090
941 4MAU 2 H C2244 heavy chain FD, SEE REMARK 999